Encapsulated and non-encapsulated nitric oxide generators used a

Details Encapsulated and non-encapsulated nitric oxide generators used a Encapsulated and non-encapsulated nitric oxide generators used a

1995-04-24

1998-09-29

Lambkin, Deborah C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

424450, A61K 3113, A61K 9127

Patent

active

058146660

ABSTRACT:
This invention relates to compositions capable of releasing nitric oxide and therapeutic methods of use thereof for the treatment of microorganism-related disease states. The composition comprises one or more nitric oxide generators, preferably encapsulated in vesicles, such as liposomes. The compositions are used therapeutically by administration to humans and animals via different routes for the treatment of infectious diseases caused by pathogenic microbes.

REFERENCES:
patent: 4781871 (1988-11-01), West, III et al.
patent: 4837028 (1989-01-01), Allen
patent: 4885173 (1989-12-01), Stanley et al.
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 4900719 (1990-02-01), Means et al.
patent: 4954526 (1990-09-01), Keefer
patent: 5002964 (1991-03-01), Loscalzo
patent: 5025001 (1991-06-01), Loscalzo et al.
patent: 5039705 (1991-08-01), Keefer et al.
patent: 5059712 (1991-10-01), Griffith
patent: 5091576 (1992-02-01), Burger
patent: 5116861 (1992-05-01), Goto et al.
patent: 5155137 (1992-10-01), Keefer et al.
patent: 5185376 (1993-02-01), Diodati et al.
patent: 5187183 (1993-02-01), Loscalzo et al.
patent: 5208233 (1993-05-01), Keefer et al.
patent: 5212204 (1993-05-01), Keefer et al.
patent: 5250550 (1993-10-01), Keefer et al.
patent: 5317040 (1994-05-01), Goldman
patent: 5366997 (1994-11-01), Keefer et al.
patent: 5374710 (1994-12-01), Tsien et al.
patent: 5389675 (1995-02-01), Christodoulou et al.
patent: 5396882 (1995-03-01), Zapol
patent: 5405919 (1995-04-01), Keefer et al.
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5525357 (1996-06-01), Keefer et al.
patent: 5576350 (1996-11-01), Wang
patent: 5583101 (1996-12-01), Stamler et al.
patent: 5622994 (1997-04-01), Carney et al.
patent: 5663364 (1997-09-01), Griffith et al.
Alston, T.A., et al., "Generation of Nitric Oxide by Enzymatic Oxidation of N-Hydroxy-N-Nitrosamines," J. Bio. Chem., vol. 260, No. 7, pp. 4069-4074 (1985).
CA 117(16): 157681e: "Liposome Containing Nitroglycerin," JP 04, 145, 020 (May 19, 1992).
Drago et al., "The Reaction of Nitrogen (II) Oxide with Various Primary and Secondary Amines," J. of Am. Chem. Soc., vol. 83, pp. 1819-1822 (1961).
Drago, "Reactions of Nitrogen (II) Oxide," Free Radicals in Inorganic Chemistry, Advances in Chemistry Series, No. 36 (American Chemical Society: Washington, D.C., 1962), pp. 143-149.
Drago, "N-Nitrosohydrooxylamine-N-sulfonates by Metathesis," Inorganic Syntheses, vol. V, pp. 120-122 (1957).
Garg et al., "Nitric Oxide-Generating Vasodilators Inhibit Mitogenesis and Proliferation of Balb/C3T3 Fibroblasts by a Cyclic GMP-Independent Mechanism," Biochem. and Biophys. Res. Comm., vol. 171, pp. 474-479 (1990).
Hansen et al., "N-Nitrosation of Secondary Amines by Nitric Oxide Via the `Drago Complex`," N-Nitroso Compounds: Occurrence and Biological Effects (Bartsch et al., eds.) IARC Scientific Publication No. 41(Int'l Agency for Research on Cancer: Lyon, 1982), pp. 21-29.
Hibbs, J.B., et al., "Nitric Oxide: A Cytotoxic Activated Macrophage Effector Molecule," Biochem. Biophys. Res. Commun., vol. 157, No. 1, pp. 87-94 (1988).
Holford et al., "Understanding the Dose-Effect Relationship: Clinical Application of Pharmacokinetic-Pharmacodynamic Models," Clinical Pharmacokinetics, vol. 6, pp. 429-453 (1981).
Howard-Flanders, "Effect of Nitric Oxide on the Radiosensitivity of Bacteria," Nature, vol. 180, pp. 1191-1192 (1957).
Hrabie, J. A., et al., "New Nitric Oxide-Releasing Zwitterions Derived From Polyamines," Journal of Organic Chemistry, vol. 58, pp. 1472-1476 (1993).
Ignarro et al., "Mechanism of Vascular Smooth Muscle Relaxation by Organic Nitrates, Nitrities, Nitroprusside and Nitric Oxide: Evidence for the Involvment of S-Nitrosothiols as Active Intermediates," J. Pharmacol. Exp. Ther., vol. 218, pp. 739-749 (1981).
Ignarro et al., "The Pharmacological and Physiological Role of Cyclic GMP in Vascular Smooth Muscle Relaxation," Annu. Rev Pharmacol. Toxicol., vol. 25, pp. 171-191 (1985).
Ignarro, "Biosynthesis and Metabolism of Endothelium-Derived Nitric Oxide," Annu. Rev. Pharmacol. Toxicol., vol. 30, pp. 535-560 (1990).
Ignarro, "Nitric Oxide: A Novel Signal Transduction Mechanism for Transcellular Communication," Hypertension (Dallas), vol. 16, pp. 477-483 (1990).
Kruszyna et al., "Red Blood Cells Generate Nitric Oxide from Directly Acting, Nitrogenous Vasodilators," Toxicol. Appl. Pharmacol., vol. 91, pp. 429-438 (1987).
Kuhn et al., "Endothelium-Dependent Vasodilatation in Human Epicardial Coronary Arteries: Effect of Prolonged Exposure to Glycerol Trinitrate or SIN-1," J. Cardiovasc. Pharmacol., vol. 14 (Suppl. 11), pp. S47-S54 (1989).
Kwon, N.S., et al., "Inhibition of Tumor Cell Ribonucleotide Reductase by Macrophage-Derived Nitric Oxide," J. Exp. Med., vol. 174, No. 4, pp. 761-767 (1991).
Longhi et al., "Metal-Containing Compounds of the Anion (C.sub.2 H.sub.5).sub.2 NN.sub.2 O.sub.2 --", Inorganic Chemistry 2, pp. 85-88 (1963).
Maragos, C.M., et al., "Complexes of NO with Nucleophiles as Agents for the Controlled Biological Release of Nitric Oxide. Vasorelaxant Effects," Journal Medical Chemistry, vol. 34, pp. 3242-3247 (1991).
Maragos, C.M., et al., "Nitric Oxide/Nucleophile Complexes Inhibit the In Vitro Proliferation of A375 Melanoma Cells via Nitric Oxide Release," Cancer Research, vol. 53, No. 3, pp. 564-568 (1993).
Marletta et al., "Unraveling the Biological Significance of Nitric Oxide," BioFactors, vol. 2, pp. 219-225 (1990).
Saavedra, J.E., et al., "Secondary Amine/Nitric Oxide Complex Ions, R.sub.2 Chemistry, vol. 57, pp. 6134-6138 (1992).
Segal et al., "Morphological Observations on the Cellular and Subcellular Destination if Intravenously Adminstered Liposomes," Br. J. Exp. Pathol., vol. 55, p. 320 (1974).
Smith et al., "Nitroprusside: A Potpourri of Biologically Reactive Intermediates," Biological Reactive Intermediates IV. Molecular and Cellular Effects and Their Impact on Human Health (Witmer et al., eds.), Advances in Experimental Medicine and Biology vol. 283 (Plenum Press, 1991), pp. 365-369.
Stuehr, D.J., et al., "Nitric Oxide a Macrophage Product Responsible for Cytostasis and Respiratory Inhibition in Tumor Target Cells," J. Exp. Med., vol. 169, No. 5, pp. 1543-1555 (1989).
Wassef et al., "Complement-Dependent Phagocytosis of Liposomes by Macrophages," Methods in Enzymology, vol. 149, pp. 124-134 (1987).
WHO Task Group on Enivronmental Health Criteria for Oxides of Nitrogen, Oxides of Nitrogen, Environmental Health Criteria 4 (World Health Organization: Geneva, 1977).
Wilcox et al., "Effects of Cyanide on the Reaction of Nitroprussside with Hemoglobin: Relevance to Cyanide Interference with the Biological Activity of Nitroprusside," Chem. Res. Toxicol., vol. 3, pp. 71-76 (1990).
Wink, D.A., et al., "DNA Deaminating Ability and Genotoxicity of Nitric Oxide and Its Progenitors," Science, vol. 254, pp. 1001-1003 (1991).
Zhu et al., "Bactericidal Activity of Peroxynitrite," Arch. Biochem and Biophys., vol. 298, No. 2, pp. 452-457 (1992).
Mancinelli et al., Applied & Environmental Microbiology, vol. 46, No. 1., pp. 198-202, Jul. 1983.
Rockett et al., Infection & Immunity, vol. 59, No. 9, pp. 3280-3283, Sep. 1991.
Incze et al., Applied Microbiology, vol. 27, No. 1, pp. 202-205, Jan. 1974.

Affiliated with

Also associated with

Rating

Encapsulated and non-encapsulated nitric oxide generators used a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Encapsulated and non-encapsulated nitric oxide generators used a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulated and non-encapsulated nitric oxide generators used a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-686763